The use of Osteomed, Osteomed Forte, and Osteo-Vit D3 in the prevention and therapy of fractures in patients with osteoporosis

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective. To analyze the literature data reflecting the medical and social significance of osteoporosis (OP), the prevention of osteoporotic fractures (OPFs), including that with Osteomed, Osteomed Forte, and Osteo-Vit D3 (Parafarm, Russia).

Material and methods. The authors analyzed research articles reflecting the medical and social significance of OP, the prevention of OPFs, including that using Osteomed, Osteomed Forte, and Osteo-Vit D3 (Parafarm, Russia),

Results. The paper presents the results of studying the effect of the new Russian drug Osteomed Forte on the hormonal status of women during the combination treatment of postmenopausal OP. The patients who took Osteomed Forte were observed to have an increase in bone mineral density and a decrease in the sizes of bone cavities, as well as their closure. Osteo-Vit D3 was a highly effective drug in preventing and treating recurrent bone fractures, including in children with OP. The efficacy of Osteo-Vit D3 in preventing recurrent fractures was noted to be highly competitive with that of calcium preparations made in foreign countries.

Conclusion. Thus, Osteomed, Osteomed Forte, and Osteo-Vit D3 (Parafarm, Russia) can be recommended for the prevention of OPFs in patients with OP, by taking into account their age, gender, comorbidity, and a personalized approach when selecting a management strategy for a particular patient.

全文:

受限制的访问

作者简介

D. Dedov

Tver State Medical University

编辑信件的主要联系方式.
Email: dedov_d@inbox.ru
ORCID iD: 0000-0002-3922-3207

Doctor of Medical Sciences, Professor

俄罗斯联邦, Tver

G. Brudyan

Voskresensk Dentistry Clinic

Email: dedov_d@inbox.ru
俄罗斯联邦, Voskresensk

I. Zhmakin

Tver State Medical University

Email: dedov_d@inbox.ru

Candidate of Medical Sciences, Associate Professor

俄罗斯联邦, Tver

K. Bakanov

Tver State Medical University

Email: dedov_d@inbox.ru

Candidate of Medical Sciences, Associate Professor

俄罗斯联邦, Tver

L. Kudrich

Tver State Medical University

Email: dedov_d@inbox.ru

Doctor of Medical Sciences, Professor

俄罗斯联邦, Tver

参考

  1. Klinicheskie rekomendatsii «Osteoporoz» Minzdrava Rossii. 2021; 105 р. (in Russ.).
  2. Yarikov A., Smirnov I., Pavlinov S. et al. Osteoporosis of the vertebral column: epidemiology, current diagnostic methods, and treatment principles. Vrach. 2020; 31 (11): 21–8 (in Russ.). doi: 10.29296/25877305-2020-11-04
  3. Yarikov A., Denisov A., Masevnin S. et al. Osteoporosis in the practice of a vertebrologist. Vrach. 2020; 31 (3): 11–8 (in Russ.). doi: 10.29296/25877305-2020-03-02
  4. Klinicheskie rekomendatsii «Padeniya u patsientov pozhilogo i starcheskogo vozrasta» Minzdrava Rossii. 2020; 74 р. (in Russ.).
  5. Delyagln V. Osteopenia and osteoporosis (modern symptomatic therapy on an outpatient basis). Vrach. 2015; 11: 31–6 (in Russ.).
  6. Barilko M., Tsurtsumiia D., Seliverstov P. et al. The application of Osteomed in practice of physician. Vrach. 2017; 3: 37–40 (in Russ.).
  7. Strukov V., Elistratov D., Kislov A. et al. Osteoporosis in geriatric practice. Vrach. 2018; 29 (6): 26–30 (in Russ.). doi: 10.29296/25877305-2018-06-05
  8. Strukov V., Elistratov D., Balykova L. et al. Fractures of bones at children and teenagers – the integrated indicator of osteoporosis. Vrach. 2015; 1: 17–20 (in Russ.).
  9. Sarkisyan N., Astryukhina P., Shamrai V. The use of zirconium dioxide in surgery: advantages and disadvantages of the material, evaluation of the effect of zirconium dioxide on osteosynthesis. Vrach. 2022; 33 (5): 14–7 (in Russ.). doi: 10.29296/25877305-2022-05-03
  10. Strukov V., Elistratov D., Vikhrev D. et al. Diagnosis and therapy of postmenopausal osteoporosis in clinical practice. Vrach. 2022; 33 (7): 54–8 (in Russ.). doi: 10.29296/25877305-2022-07-10
  11. Dervis E. Oral implications of osteoporosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005; 100 (3): 349–56. doi: 10.1016/j.tripleo.2005.04.010
  12. Bałczewska E. Analysis of periodontal status in females with reduced bone minerall density. Czas Stomatol. 2005; 58: 798–808.
  13. Peng J., Wang H., Liu Z. et al. Real-world study of antiresorptive-related osteonecrosis of jaw based on the US food and drug administration adverse event reporting system database. Front Pharmacol. 2022; 13: 1017391. doi: 10.3389/fphar.2022.1017391
  14. Strukov V., Elistratov D., Balykova L. et al. Effect of Osteomed Forte on hormonal status and course of osteoporosis in postmenopausal women with androgen deficiency. Vrach. 2015; 3: 28–32 (in Russ.).
  15. Jones O., Strukov V., Kislov A. et al. Comorbid osteoporosis: challenges and new diagnostic opportunities (Part 2). Vrach. 2017; 11: 25–9 (in Russ.).
  16. Yarmolovich R., Salaev A. Osteomed Forte used to improve the regenerative capacity of bone tissue in diaphyseal tubular bone fractures. Vrach. 2020; 31 (5): 63–6 (in Russ.). doi: 10.29296/25877305-2020-05-14
  17. Romanov D., Polikarpochkin A., Polikarpochkinа E. Osteomed Forte in the treatment of patients with ankle injuries. Vrach. 2020; 31 (8): 70–4 (in Russ.). doi: 10.29296/25877305-2020-08-11
  18. Kuptsova T., Kislov A., Strukov V. et al. Osteo-Vit D3 in the treatment of children with recurrent bone fractures in osteoporosis. Vrach. 2016; 1: 46–7 (in Russ.).
  19. Strukov V.I., Katyushina Yu.G., Eremina N.V., Filippova O.V. Osteomed is an effective regulator of bone mineral density and closure of cavities in the treatment of presenile and senile osteoporosis. Poliklinika. 2013; 1: 90–1 (in Russ.).
  20. Strukov V.I., Katyushina Yu.G., Eremina N.V. et al. Discovery in the treatment of presenile and senile osteoporosis. International Journal of Applied and Fundamental Research. 2013; 9: 122–4 (in Russ.).
  21. Prokhorov M., Kislov A., Elistratov D., et al. Effect of Osteomed on consolidation of bone fractures. Vrach. 2016; 2: 68–9 (in Russ.).
  22. Peshekhonova L., Peshekhonov D., Krasyukov P. The clinical efficiency of using Osteomed, Osteomed Forte, and Osteo-Vit D3 in patients with secondary osteoporosis in rheumatoid arthritis. Vrach. 2020; 31 (4): 68–74 (in Russ.). doi: 10.29296/25877305-2020-04-12
  23. Yurova O., Marchenkova L. The experience of using of comprehensive rehabilitation program with dietary supplements Osteomed Forte in patients with a jsteoporotic distal forearm fracture. Vrach. 2020; 31 (2): 47–52 (in Russ.). doi: 10.29296/25877305-2020-02-11
  24. Kashpanov M.D., Popov V.V., Novikova I.A. Osteoporosis: prevention of fractures with OSTEOMED FORTE by PARAFARM. Meditsinskaya sestra. 2022; 8: 11–4 (in Russ.). doi: 10.29296/25879979-2022-08-02

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russkiy Vrach Publishing House, 2023
##common.cookie##